Why Compugen Stock Crumbled Today
Stocks in the ever-volatile biotech sector have many ups and downs, and Monday wasn't one of the ups for Compugen (NASDAQ: CGEN). The cancer treatment developer published its latest set of quarterly results, and investors showed their displeasure by trading the company's shares down by over 9%. Before market open, Compugen presented its third-quarter figures.